1996
DOI: 10.1097/00003226-199601000-00006
|View full text |Cite
|
Sign up to set email alerts
|

Corneal Endothelium in Mucopolysaccharide Storage Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
21
1
1

Year Published

1999
1999
2011
2011

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 27 publications
(27 citation statements)
references
References 0 publications
4
21
1
1
Order By: Relevance
“…Our results were consistent with previously published data that characterized this compartment (Chan et al, 1983 ;Del Monte et al, 1983 ;Lavery et al, 1983 ;Mollard et al, 1996 ;Spencer, 1996). Electron micrographs revealed the presence of small to moderately sized secondary lysosomes in the corneal epithelium from human MPS I and III, as well as cats with MPS I and VI.…”
Section: Resultssupporting
confidence: 94%
See 1 more Smart Citation
“…Our results were consistent with previously published data that characterized this compartment (Chan et al, 1983 ;Del Monte et al, 1983 ;Lavery et al, 1983 ;Mollard et al, 1996 ;Spencer, 1996). Electron micrographs revealed the presence of small to moderately sized secondary lysosomes in the corneal epithelium from human MPS I and III, as well as cats with MPS I and VI.…”
Section: Resultssupporting
confidence: 94%
“…In this respect, the abnormal accumulation of substrate within lysosomes in storage diseases might indicate a compromised endothelial function that may be involved in the alteration of stromal structure. However, in feline MPS VI, there was no abnormal storage within the corneal endothelium (Mollard et al, 1996), and the cat corneas are cloudy. Furthermore, the endothelial and lysosomal compartments were comparable in human MPS I and III where corneas are cloudy and clear, respectively.…”
Section: Discussionmentioning
confidence: 90%
“…Corneal clouding involving all layers (epithelium, stroma and endothelium) (Gills et al 1965;Mollard et al 1996;Alroy et al 1999), ocular hypertension or glaucoma with glaucomatous optic nerve heads (Spellacy et al 1980;Nowaczyk et al 1988;Mullaney et al 1996;Guffon et al 1998) and chronic papilloedema with subsequent optic atrophy (Collins et al 1990;Gullingsrud et al 1998;Wraith 2005) are found in patients with MPS I-Hurler. Reduced corneal opacities after SCT have been reported but outcomes vary (Hobbs et al 1981;Summers et al 1989;Vellodi et al 1997;Guffon et al 1998;Gullingsrud et al 1998;Souillet et al 2003;Connell et al 2008).…”
mentioning
confidence: 99%
“…Alroy et al, demonstraram que os depósitos corneais geralmente estão associados a anomalias esqueléticas, como é o caso em questão (9) . Os mucopolissacarídeos constituem a substância fundamental da córnea (4 a 4,5% do peso da córnea seca), sendo nestas doenças encontrado um excesso de mucopolissacarí-deos nos ceratócitos e estroma, e, em alguns casos, no epitélio e endotélio corneais (4,10) . Devido à instabilidade em relação à degradação fisiológica destes mucopolissacarídeos, ocorrem várias alterações de significados variáveis no globo ocular podendo levar à perda da transparência corneal difusa (cerca de 75% dos pacientes com MPS tipo VI apresentam opacificação corneal de intensidade variável) como relatam alguns autores (4) apresentando um aspecto de vidro moído associado a opacidades puntiformes finas no estroma profundo.…”
Section: Discussionunclassified